STOCK TITAN

NANOBIOTIX to Participate in Multiple Investor Conferences in November

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Nanobiotix (NASDAQ: NBTX), a late-clinical stage biotechnology company focused on nanoparticle-based cancer treatments, announces participation in three major healthcare conferences in November 2024. The company will engage in fireside chats at Guggenheim's Inaugural Healthcare Innovation Conference (Nov 11, Boston), the Stifel Healthcare Conference (Nov 18, New York), and the Jefferies London Healthcare Conference (Nov 20, London). Company executives Laurent Levy (CEO) and Bart van Rhijn (CFO) will present at these events. All sessions will be webcast live and available for replay on the company's investor relations website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

-4.81%
1 alert
-4.81% News Effect

On the day this news was published, NBTX declined 4.81%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

~ Guggenheim’s Inaugural Healthcare Innovation Conference, Nov 11-13 ~

~ Stifel Healthcare Conference, Nov 18-19 ~

~ Jefferies London Healthcare Conference, Nov 19-21 ~

PARIS and CAMBRIDGE, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in fireside chats at following conferences:

Guggenheim’s Inaugural Healthcare Innovation Conference
Date: Monday, November 11, 2024
Time: 4pm ET / 10pm CET
Location: Boston, MA
Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial & Business Officer of Nanobiotix
Webcast link: Click here

Stifel Healthcare Conference
Date: Monday, November 18, 2024
Time: 4:45pm ET / 10:45pm CET
Location: New York, NY
Presenter: Bart van Rhijn, Chief Financial & Business Officer of Nanobiotix
Webcast link: Click here

Jefferies London Healthcare Conference
Date: Wednesday, November 20, 2024
Time: 1pm GMT / 8am ET / 2pm CET
Location: London, UK
Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial & Business Officer of Nanobiotix
Webcast link: Click here

The fireside chats will be webcast live from the events page of the Investors section of the Company’s website. Replay of the webcast will be available following the event.

About NANOBIOTIX

Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity. The Company’s philosophy is rooted in the concept of pushing past the boundaries of what is known to expand possibilities for human life.

Incorporated in 2003, Nanobiotix is headquartered in Paris, France and is listed on Euronext Paris since 2012 and on the Nasdaq Global Select Market in New York City since December 2020. The Company has subsidiaries in Cambridge, Massachusetts (United States) amongst other locations.

Nanobiotix is the owner of more than 25 patent families associated with three (3) nanotechnology platforms with applications in 1) oncology; 2) bioavailability and biodistribution; and 3) disorders of the central nervous system.

For more information about Nanobiotix, visit us at www.nanobiotix.com or follow us on LinkedIn and Twitter.

Contacts

Nanobiotix 

Communications Department
Brandon Owens
VP, Communications
+1 (617) 852-4835
contact@nanobiotix.com

Investor Relations Department
Craig West
SVP, Investor Relations
+1 (617) 583-0211
investors@nanobiotix.com
 
Media Relations 

FR – Ulysse Communication
Laurent Wormser
+ 33 (0)6 13 12 04 04
lwormser@ulysse-communication.com   

Global – LifeSci Advisors
Kevin Gardner
+1 (617) 283-2856
kgardner@lifesciadvisors.com
 

Attachment


FAQ

What upcoming investor conferences will Nanobiotix (NBTX) attend in November 2024?

Nanobiotix will participate in three conferences: Guggenheim's Healthcare Innovation Conference (Nov 11), Stifel Healthcare Conference (Nov 18), and Jefferies London Healthcare Conference (Nov 20).

Where can I watch Nanobiotix (NBTX) conference presentations in November 2024?

All fireside chats will be webcast live from the events page of the Investors section of Nanobiotix's website, with replays available after each event.

Which Nanobiotix executives will present at the November 2024 healthcare conferences?

CEO Laurent Levy and CFO Bart van Rhijn will present at the conferences, with both executives attending the Guggenheim and Jefferies conferences, while van Rhijn will present solo at the Stifel conference.

What time is Nanobiotix's presentation at the Jefferies London Healthcare Conference?

Nanobiotix will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024, at 1pm GMT (8am ET / 2pm CET).
Nanobiotix S.A.

NASDAQ:NBTX

NBTX Rankings

NBTX Latest News

NBTX Latest SEC Filings

NBTX Stock Data

1.03B
48.40M
11.9%
0.05%
Biotechnology
Healthcare
Link
France
Paris